Nascent Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$2,087,682 over the previous period. Total operating expenses were $2,229,879.

Profit Margin

Nascent Biotech, Inc. (OTC:NBIO): Profit margin
2015 0 -2.15M
2016 0 -4.14M
2017 3M 1.13M 37.9%
2018 0 -2.22M
2019 0 -1.36M
2020 0 -4.09M
2021 750K -1.31M -175.31%
2022 1M -147.70K -14.77%
2023 0 -2.80M
2024 0 -2.08M

NBIO Income Statement (2015 โ€“ 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
001M750K0003M00
Cost of revenue
319.50K000000000
Gross profit
-319.50K01M750K0003M00
Operating exp.
Research and development
203.44K270.52K197.40K321.93K293.70K254.00K1.19M486.92K1.15M1.67M
Selling and marketing
0000000000
Total operating expenses
2.22M2.14M1.45M2.15M3.44M1.36M2.22M1.57M3.87M2.12M
Operating income
-2.22M-2.15M-457.05K-1.40M-3.44M-1.36M-2.22M1.42M-3.87M-2.14M
Other income (expenses), net
142.19K-645.21K-13.33K441.60K-556.84K41346-50.48K-280K-29.05K
Income before tax
-2.08M-2.80M-470.39K-958.76K-4.00M-1.36M-2.22M1.37M-4.15M-2.15M
Income tax expense
02.21M-322.68K356.04K86.62K-41-471240K-4995.99K
Net income
-2.08M-2.80M-147.70K-1.31M-4.09M-1.36M-2.22M1.13M-4.14M-2.15M
Earnings per share
Basic EPS
-0.01-0.02-0.00-0.01-0.12-0.04-0.080.05-0.21-0.15
Diluted EPS
-0.01-0.02-0.00-0.01-0.12-0.04-0.080.05-0.21-0.15
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source